PSI Establishes Permanent Operation in Israel

ZUG, Switzerland--()--PSI CRO, a global full-service contract research organization, announced today the establishment of its permanent operation in Israel.

PSI has worked in Israel on behalf of pharmaceutical and biotech sponsors for a number of years already. They have gained vast experience in the areas of oncologyhematologyhemophiliainfectious diseasesCNS and other therapeutic areas. The impressive potential of the region to facilitate patient enrollment prompted PSI to think about establishing a permanent operational base in the region.

Ronit Pakula will lead the clinical operations team in Israel. "I am excited about PSI's unique differentiator and our ability to complete global clinical trials on time," says Ms. Pakula. "I hope our team in Israel can play a significant role in achieving this common goal. PSI is full of opportunities, we really like that here in Israel."

About PSI CRO:

PSI is a privately-owned, full-service contract research organization (CRO), operating globally. PSI's reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI's global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug (Zürich), Switzerland at 113a Baarerstrasse 6300.



Barbara Breen, +1 847-202-1120
[email protected]


Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.